blindness from glp 1 GLP-1 meds and vision: what the scary headlines DON'T say Ozempic Blindness Lawsuit; CGM Integrates

Therefore, while efforts undoubtedly need to be intensified towards preventing the onset of the disease and making lifestyle modifications (a fundamental aspect of the therapy for every patient with T2DM), it is clear, as indicated by the most recent guidelines [78], that the pharmacological approach should focus on timely treatment that leaves no room for therapeutic inertia and employs medications that are as effective as possible in both metabolic control and the prevention of chronic complications

Due to the differences in the native IGF-1/IGFBP complexes, extensive efforts have been focused on their disruption

Toxoplasma gondii seropositivity in patients with depressive and anxiety disorders

These medications include semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist with a slightly different mechanism